Biosketch
Richard G. Stefanacci, D.O., M.G.H., M.B.A., A.G.S.F., C.M.D.

As the Executive Director of the University of the Sciences in Philadelphia’s Center for Medicare Medication Management (cm³), Dr. Stefanacci continues to build upon his work as Health Policy Scholar at the Center for Medicare and Medicaid Services (CMS), as well as a geriatrician and professor at the first college of pharmacy in the country. At CMS he spent a year working on the policy and implementation of the Medicare Part D Pharmacy Benefit especially regarding access issues for frail elderly.

Dr. Stefanacci has been involved in LTC facilities since childhood and remains active in the LTC facilities today. Having served as Medical Director for several nursing facilities as well as continuing care retirement communities, he is well versed in the needs of these facilities’ residents. He completed his clinical training at the University of Medicine and Dentistry of New Jersey in Internal Medicine and a fellowship in geriatrics. Dr. Stefanacci's geriatric experience includes over a decade as a medical director in several roles including a large primary care private practice, a full risk provider group, a Medicare + Choice HMO (M+C), and just recently for a PACE (Program for All-inclusive Care for the Elderly) program in Philadelphia. As a geriatrician for the St. Agnes LIFE program, Dr. Stefanacci is involved not only in direct patient care but in the implementation of quality assurance and utilization managed initiatives for the frail elderly. Currently Dr. Stefanacci is working with Newcourtland on several innovative new programs, including the introduction of an electronic dispensing and prescribing medication system throughout their network of LTC facilities. Newcourtland manages 1500 LTC beds in Philadelphia plus a recently opened LIFE center. Given this strong background in LTC Dr. Stefanacci has been tasked with developing at the university The Institute for Geriatric Studies at Mayes College for Healthcare Business & Policy – the institute will support a Geriatric Health Program which will be for both undergraduates and graduate students. The Geriatric Healthcare Program will not only provide additional experts in this growing area but also serve as a national and international resource for all stakeholders involved in geriatric care.

He holds two Master’s degrees one in Geriatric Health the other Business Administration. He is board certified in Quality Assurance and Utilization as well as being a Certified Medical Director (CMD). Dr. Stefanacci has served on the board of trustees at his alma mater A.T. Still University as well as the National PACE Association as well as participates actively in the American Medical Directors Association (AMDA), Academy of Managed Care Pharmacy, American Society of Consultant Pharmacist (ASCP), and the American Geriatrics Society (AGS). He has achieved recognition as a fellow in both the College of Physicians of Philadelphia and AGS as well as becoming an honorary lifetime member of ASCP. In addition to writing and lecturing extensively, he serves as editor-in-chief of the Assisted Living Consult and Medicare Patient Management as well as serving on the editorial boards of Consultant Pharmacist, American Psychiatry News, LTC Interface, Managed Care, and Jefferson’s Health Policy newsletter.
Other specific areas of focus include the Alzheimer’s Disease Screening and Treatment Discussion Group as well as the Alliance for Advancing Senior Health which is working with organizations that have common goals to increase the visibility of senior health issues and enhance the public health information infrastructure designed for and available to America's seniors.

When asked, Dr. Stefanacci will state that his greatest accomplishment is “G4theG” which stands for the Go4theGoal Foundation (www.G4theG.org). A 501(c)3 public charity which was founded with his children, family and friends when his oldest son Richard was diagnosised with Ewing Sarcoma in May of 2006 developing an intense focus after his son’s death on June 12th 2007. Just in a little over a year the foundation has raised well over a million dollars assisting several hundred child affected by cancer while funding cutting edge research to find a cure.